Chris Brinsmead joins the Board of Kinapse
pharmafile | October 5, 2010 | News story | | Kinapse
London, UK
The Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a Non-Executive Director of Kinapse. Chris has had a long and distinguished career in the pharmaceutical industry, notably with Astra Zeneca where he was the President of their UK business. He has also recently served as President of the Association of the British Pharmaceutical Industry (ABPI).
Nick Edwards, Chairman of Kinapse Ltd., said, “I am delighted that Chris has agreed to join the Board of Kinapse. He will bring an extremely valuable perspective to our leadership of the business. We all look forward to working with him as Kinapse pursues its aggressive growth agenda.”
Kinapse Ltd.
About Kinapse
Kinapse provides consulting and outsourcing services to the global life sciences industries.
Our clients include many of the world’s leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organisations and life sciences service providers.
Kinapse specialises in addressing the challenges of life sciences. We understand the complex issues faced throughout the life sciences value chain and offer innovative insights, advice and service delivery to our clients.
Contact:
info@kinapse.com, +44 (0)208 946 7600
Related Content
Service Insight: Discovery metrics – creating the right balance
SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in …
The Project Management Office – Accelerating Project Management Maturity
Success in the life sciences industry depends on allocation of scarce resource to the right …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore …
